Upgrade to SI Premium - Free Trial

Rite Aid (RAD) Is Facing More Reimbursement Pressure - Goldman Sachs

December 20, 2018 7:25 AM
Goldman Sachs analyst, Robert Jones, reiterated his Sell rating on shares of Rite-Aid (NYSE: RAD) after the company reported a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View

Next Articles